We have some tools to control bacteria, like antibiotics, but antibiotic resistance is a growing problem that is a threat to public health... | Microbiology ...

Vaxcyte (PCVX) is a clinical-stage vaccine innovation company focused on developing next-generation vaccines to protect people from serious bacterial infectious diseases. While Vaxcyte is still a ...

FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussions OS ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

Every year, the College of Natural Sciences invites faculty, staff and students to send in the most striking and fascinating ...

XDR typhoid spreads across regions, weakening key antibiotics and raising urgent calls for vaccination, new drugs and stronger global surveillance.

Precision-fermented fats are the new invention that promises to be better for the heart. Here is exactly what it is, how it ...

Q4 2025 Earnings Call February 26, 2026 8:30 AM ESTCompany ParticipantsLuis Sanay - Vice President of Investor RelationsJohn Jacobs ...

Learn how BeSEC enables precise analysis of antibody aggregation and molecular weight through dual-angle light scattering.

FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussionsOS Therapies on track to complete clinical data submission by the end of Q1 2026New ...

SAN CARLOS, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced financial results for the fourth quarter and full year ...